These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2971135)

  • 1. Interleukin-1 directly regulates hormone-dependent human breast cancer cell proliferation in vitro.
    Paciotti GF; Tamarkin L
    Mol Endocrinol; 1988 May; 2(5):459-64. PubMed ID: 2971135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M; Bicknell R; Harris AL
    Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 differentially affects the proliferation of a hormone-dependent and a hormone-independent human breast cancer cell line in vitro and in vivo.
    Paciotti GF; Tamarkin L
    Anticancer Res; 1988; 8(6):1233-9. PubMed ID: 3265314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
    Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
    Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine.
    Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF
    Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells.
    Chen L; Shulman LM; Revel M
    J Biol Regul Homeost Agents; 1991; 5(4):125-36. PubMed ID: 1803860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro.
    Danforth DN; Sgagias MK
    Cancer Res; 1991 Mar; 51(5):1488-93. PubMed ID: 1997187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
    Gooch JL; Lee AV; Yee D
    Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro demonstration of breast cancer tumor cell sub-populations based on interleukin-1/tumor necrosis factor induction of interleukin-8 expression.
    Pantschenko AG; Pushkar I; Miller LJ; Wang YP; Anderson K; Peled Z; Kurtzman SH; Kreutzer DL
    Oncol Rep; 2003; 10(4):1011-7. PubMed ID: 12792762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L; Gudas LJ
    J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity.
    Costantino A; Vinci C; Mineo R; Frasca F; Pandini G; Milazzo G; Vigneri R; Belfiore A
    Endocrinology; 1996 Oct; 137(10):4100-7. PubMed ID: 8828463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between human cell growth response to interleukin 1 and receptor binding.
    Gaffney EV; Koch G; Tsai SC; Loucks T; Lingenfelter SE
    Cancer Res; 1988 Oct; 48(19):5455-9. PubMed ID: 2970890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin receptor expression and function in human breast cancer cell lines.
    Milazzo G; Giorgino F; Damante G; Sung C; Stampfer MR; Vigneri R; Goldfine ID; Belfiore A
    Cancer Res; 1992 Jul; 52(14):3924-30. PubMed ID: 1617668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro.
    Danforth DN; Sgagias MK
    Cancer Res; 1993 Apr; 53(7):1538-45. PubMed ID: 8453620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative activity of gossypol and gossypolone on human breast cancer cells.
    Gilbert NE; O'Reilly JE; Chang CJ; Lin YC; Brueggemeier RW
    Life Sci; 1995; 57(1):61-7. PubMed ID: 7596222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E; Day BW
    Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines.
    Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
    Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.